Research2 sources
DeepMind's ultra-powerful AI for genome mapping wows scientists
Nature · By Ewen Callaway ·
The Brief · written from 2 sources
- Google DeepMind announced AlphaGenome 2 on 2026-11-11, a tool that predicts how DNA sequences and their variations affect specific human cell types and disease.
- According to Nature, AlphaGenome 2 can predict the types of cells where a DNA variant is likely to act.
- Nature's report says the tool has impressed scientists, though the sources provided give no independent validation figures.
Why it matters
By indicating which cell types a DNA variant is likely to act in, the tool could help researchers narrow down how genetic variants contribute to disease.
Who’s affected
- geneticists and genomics researchers
- biomedical researchers studying disease mechanisms
- researchers interested in AI tools for gene regulation
- AlphaGenome 2
- #genomics
- #dna variants
- #gene regulation
- #artificial intelligence
- #disease mechanisms
Nature, Published online: 11 November 2026; doi:10.1038/d41586-026-03673-0 AlphaGenome 2 can predict the types of cells where a DNA variant is likely to act.
Timeline
Full coverage · 2 sources
- 7d ago ↗
Google DeepMind News
AlphaGenome 2: Deciphering how cells read DNA to better understand disease - 8d ago ↗
nature.com
DeepMind's ultra-powerful AI for genome mapping wows scientists